Nanoviricides Stock Price Prediction

NNVC Stock  USD 1.18  0.02  1.72%   
The RSI of NanoViricides' share price is above 70 at the present time. This indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling NanoViricides, making its price go up or down.

Oversold Vs Overbought

71

 
Oversold
 
Overbought
NanoViricides stock price prediction is an act of determining the future value of NanoViricides shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of NanoViricides' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of NanoViricides and does not consider all of the tangible or intangible factors available from NanoViricides' fundamental data. We analyze noise-free headlines and recent hype associated with NanoViricides, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting NanoViricides' stock price prediction:
EPS Estimate Current Year
(0.73)
EPS Estimate Next Year
(1.11)
Wall Street Target Price
6.5
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of NanoViricides based on different types of headlines from major news networks to social media. The NanoViricides stock price prediction module provides an analysis of price elasticity to changes in media outlook on NanoViricides over a specific investment horizon. Using NanoViricides hype-based prediction, you can estimate the value of NanoViricides from the perspective of NanoViricides response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards NanoViricides using NanoViricides' stock options and short interest. It helps to benchmark the overall future attitude of investors towards NanoViricides using crowd psychology based on the activity and movement of NanoViricides' stock price.

NanoViricides Implied Volatility

    
  0.0  
NanoViricides' implied volatility exposes the market's sentiment of NanoViricides stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if NanoViricides' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that NanoViricides stock will not fluctuate a lot when NanoViricides' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in NanoViricides. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in NanoViricides to buy its stock at a price that has no basis in reality. In that case, they are not buying NanoViricides because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

NanoViricides after-hype prediction price

    
  USD 1.18  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out NanoViricides Basic Forecasting Models to cross-verify your projections.
For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NanoViricides' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.112.155.38
Details
Naive
Forecast
LowNextHigh
0.021.004.22
Details
1 Analysts
Consensus
LowTargetHigh
4.785.255.83
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.19-0.19-0.19
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as NanoViricides. Your research has to be compared to or analyzed against NanoViricides' peers to derive any actionable benefits. When done correctly, NanoViricides' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in NanoViricides.

NanoViricides After-Hype Price Prediction Density Analysis

As far as predicting the price of NanoViricides at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NanoViricides or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of NanoViricides, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

NanoViricides Estimiated After-Hype Price Volatility

In the context of predicting NanoViricides' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NanoViricides' historical news coverage. NanoViricides' after-hype downside and upside margins for the prediction period are 0.06 and 4.41, respectively. We have considered NanoViricides' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.18
1.18
After-hype Price
4.41
Upside
NanoViricides is risky at this time. Analysis and calculation of next after-hype price of NanoViricides is based on 3 months time horizon.

NanoViricides Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as NanoViricides is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NanoViricides backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NanoViricides, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.27 
3.23
 0.00  
  0.19 
5 Events / Month
10 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.18
1.18
0.00 
32,300  
Notes

NanoViricides Hype Timeline

NanoViricides is now traded for 1.18. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.19. NanoViricides is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at 0.27%. %. The volatility of related hype on NanoViricides is about 466.92%, with the expected price after the next announcement by competition of 1.37. The company has price-to-book ratio of 1.18. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NanoViricides recorded a loss per share of 0.8. The entity last dividend was issued on the 24th of September 2019. The firm had 1:20 split on the 24th of September 2019. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days.
Check out NanoViricides Basic Forecasting Models to cross-verify your projections.
For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.

NanoViricides Related Hype Analysis

Having access to credible news sources related to NanoViricides' direct competition is more important than ever and may enhance your ability to predict NanoViricides' future price movements. Getting to know how NanoViricides' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NanoViricides may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RNXTRenovoRx 0.06 10 per month 5.63  0.05  12.78 (7.78) 42.62 
AXLAAxcella Health 3.92 3 per month 12.62  0.09  59.22 (26.94) 336.88 
ADILAdial Pharmaceuticals(0.05)10 per month 7.31  0.1  27.90 (15.64) 128.01 
BTTXBetter Therapeutics 0.00 0 per month 0.00 (0.09) 15.79 (20.00) 100.15 
KTTAPasithea Therapeutics Corp 1.06 3 per month 3.98 (0.01) 9.51 (6.91) 22.47 
ZIVOZivo Bioscience 7.17 2 per month 0.00 (0.49) 9.67 (14.29) 32.07 
QNRXQuoin Pharmaceuticals Ltd(0.11)8 per month 0.00 (0.34) 4.69 (9.67) 53.64 
ABIOARCA Biopharma 0.02 7 per month 0.90  0.13  3.14 (3.05) 95.29 
ABVCABVC Biopharma(0.03)10 per month 0.00 (0.07) 5.60 (6.25) 30.83 
INDPIndaptus Therapeutics(0.16)6 per month 4.39  0.11  12.90 (7.20) 24.83 
FBRXForte Biosciences(0.02)8 per month 4.67  0.01  7.94 (5.63) 29.50 
RZLTRezolute 0.07 10 per month 3.80  0.33  12.17 (5.98) 21.05 
TPSTTempest Therapeutics(0.09)9 per month 0.00 (0.04) 7.26 (7.36) 56.46 
CMRAComera Life Sciences(0.01)7 per month 0.00 (0.17) 18.18 (14.71) 55.21 
THRXTheseus Pharmaceuticals 0.11 8 per month 0.56  0.16  4.93 (2.71) 53.69 
ERASErasca Inc(0.16)8 per month 3.78 (0) 7.10 (6.31) 25.03 
AMTIApplied Molecular TransportInc(0.02)7 per month 4.23  0.09  12.50 (6.67) 37.87 

NanoViricides Additional Predictive Modules

Most predictive techniques to examine NanoViricides price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NanoViricides using various technical indicators. When you analyze NanoViricides charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About NanoViricides Predictive Indicators

The successful prediction of NanoViricides stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NanoViricides, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NanoViricides based on analysis of NanoViricides hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NanoViricides's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NanoViricides's related companies.
 2021 2022 2023 2024 (projected)
Net Debt To EBITDA1.891.040.941.22
Intangibles To Total Assets0.01450.01970.02270.023

Story Coverage note for NanoViricides

The number of cover stories for NanoViricides depends on current market conditions and NanoViricides' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NanoViricides is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NanoViricides' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

NanoViricides Short Properties

NanoViricides' future price predictability will typically decrease when NanoViricides' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of NanoViricides often depends not only on the future outlook of the potential NanoViricides' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NanoViricides' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding11.6 M
Cash And Short Term Investments8.1 M
When determining whether NanoViricides offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NanoViricides' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nanoviricides Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nanoviricides Stock:
Check out NanoViricides Basic Forecasting Models to cross-verify your projections.
For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for NanoViricides Stock analysis

When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
CEOs Directory
Screen CEOs from public companies around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Return On Assets
(0.36)
Return On Equity
(0.58)
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.